168 related articles for article (PubMed ID: 33724800)
21. Organization of H locus conserved repeats in Leishmania (Viannia) braziliensis correlates with lack of gene amplification and drug resistance.
Dias FC; Ruiz JC; Lopes WC; Squina FM; Renzi A; Cruz AK; Tosi LR
Parasitol Res; 2007 Aug; 101(3):667-76. PubMed ID: 17393181
[TBL] [Abstract][Full Text] [Related]
22. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
23. Identifying miltefosine-resistant key genes in protein-protein interactions network and experimental verification in Iranian Leishmania major.
Lari N; Jalal R; Minuchehr Z; Rajabian Noghondar M
Mol Biol Rep; 2019 Oct; 46(5):5371-5388. PubMed ID: 31385238
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
[TBL] [Abstract][Full Text] [Related]
27. Major changes in chromosomal somy, gene expression and gene dosage driven by Sb
Patino LH; Imamura H; Cruz-Saavedra L; Pavia P; Muskus C; Méndez C; Dujardin JC; Ramírez JD
Sci Rep; 2019 Jul; 9(1):9485. PubMed ID: 31263131
[TBL] [Abstract][Full Text] [Related]
28. Optimized CRISPR-Cas9 Genome Editing for
Zhang WW; Lypaczewski P; Matlashewski G
mSphere; 2017; 2(1):. PubMed ID: 28124028
[TBL] [Abstract][Full Text] [Related]
29. Genomic Diversification, Structural Plasticity, and Hybridization in
Patino LH; Muñoz M; Cruz-Saavedra L; Muskus C; Ramírez JD
Front Cell Infect Microbiol; 2020; 10():582192. PubMed ID: 33178631
[No Abstract] [Full Text] [Related]
30. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
Rangel H; Dagger F; Hernandez A; Liendo A; Urbina JA
Antimicrob Agents Chemother; 1996 Dec; 40(12):2785-91. PubMed ID: 9124841
[TBL] [Abstract][Full Text] [Related]
31. Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.
Alves-Ferreira EV; Toledo JS; De Oliveira AH; Ferreira TR; Ruy PC; Pinzan CF; Santos RF; Boaventura V; Rojo D; López-Gonzálvez Á; Rosa JC; Barbas C; Barral-Netto M; Barral A; Cruz AK
PLoS Negl Trop Dis; 2015; 9(9):e0004018. PubMed ID: 26366580
[TBL] [Abstract][Full Text] [Related]
32. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
[TBL] [Abstract][Full Text] [Related]
33. Identification of divergent Leishmania (Viannia) braziliensis ecotypes derived from a geographically restricted area through whole genome analysis.
S L Figueiredo de Sá B; Rezende AM; Melo Neto OP; Brito MEF; Brandão Filho SP
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007382. PubMed ID: 31170148
[TBL] [Abstract][Full Text] [Related]
34. Evolutionary aspect of Miltefosine transporter proteins in Leishmania major.
Kabra R; Singh S
Adv Protein Chem Struct Biol; 2022; 130():399-418. PubMed ID: 35534115
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
Crone CG; Helleberg M
J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
[No Abstract] [Full Text] [Related]
36. Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis.
Neira LF; Mantilla JC; Escobar P
J Antimicrob Chemother; 2019 Jun; 74(6):1634-1641. PubMed ID: 30815688
[TBL] [Abstract][Full Text] [Related]
37. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
[TBL] [Abstract][Full Text] [Related]
38. Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.
Turner KG; Vacchina P; Robles-Murguia M; Wadsworth M; McDowell MA; Morales MA
PLoS Negl Trop Dis; 2015; 9(7):e0003948. PubMed ID: 26230675
[TBL] [Abstract][Full Text] [Related]
39. Relation between variation in copy number of ribosomal RNA encoding genes and size of harbouring chromosomes in Leishmania of subgenus Viannia.
Inga R; De Doncker S; Gomez J; Lopez M; Garcia R; Le Ray D; Arevalo J; Dujardin JC
Mol Biochem Parasitol; 1998 May; 92(2):219-28. PubMed ID: 9657327
[TBL] [Abstract][Full Text] [Related]
40. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
Das M; Saudagar P; Sundar S; Dubey VK
FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
